Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stevia venture

This article was originally published in The Tan Sheet

Executive Summary

A joint venture by stevia producer GLG Life Tech and fitness product firm Weider Global Nutrition aims to bring dietary and tabletop supplements made with stevia leaf extracts into international markets, GLG announces Sept. 9. GLG Weider Sweet Naturals Corp. will leverage the stevia extraction expertise of Vancouver, British Columbia-based GLG, and the sales and distribution capacities of Salt Lake City-based Weider to "provide consumers a great tasting, natural and zero-calorie alternative to artificial sweeteners and calorie-laden sugar," says GLG President Brian Palmieri. Though multiple U.S. companies are either marketing or developing stevia-based sweeteners, FDA has not declared the substance safe as a food additive and consumer groups have questioned stevia safety data (1"The Tan Sheet" Sept. 1, 2008, p. 16)

You may also be interested in...

Stevia Safety Certifications Lacking FDA OK Called Into Question

The Center for Science in the Public Interest maintains FDA's process for certifying a substance as generally recognized as safe is insufficient and has left the door open for the marketing of potentially unsafe sweeteners made from the stevia leaf

UNPA On Team Awarded $300,000 US Grant For Project To Improve Natural Health Trade With China

Grant from Department of Commerce Market Development Cooperator Program funds project for four years. In addition to grant, the project partners – UNPA, National Animal Supplement Council, Eurofins Scientific testing company and China Inspections and Testing Society – get DoC assistance.

Industry Self-Regulation Group’s Knowledge Of Drug Types Questioned By US Homeopathic Firm

Avadim Health argues National Advertising Division expects substantiation for its homeopathic topical claims at the same level FDA requires for NDAs. NAD also said although FTC’s competent, reliable scientific evidence standard is “flexible” to some degree, pain claims are held to a more rigid standard.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts